Camp4 stock gains after earning bullish views (CAMP:NASDAQ)
Nov 5, 2024 · Recently IPO'ed biotech Camp4 Therapeutics (NASDAQ: CAMP) recorded its best intraday gains since its public debut in October as J.P. Morgan and Piper Sandler launched its coverage with Overweight ...
CAMP4 THERAPEUTICS CORPORATION (CAMP) Latest Stock News …
Get the latest CAMP4 THERAPEUTICS CORPORATION (CAMP) stock news and headlines to help you in your trading and investing decisions.
CAMP4 is latest to eye IPO, while Upstream spells out $182M plan
Oct 7, 2024 · RNA biotech CAMP4 Therapeutics has marked out plans for a $67 million IPO, with inflammation-focused Upstream Bio pegging its own ambitions at $182 million.
CAMP4 THERAPEUTICS CORPORATION (CAMP) Stock Price, News…
Find the latest CAMP4 THERAPEUTICS CORPORATION (CAMP) stock quote, history, news and other vital information to help you with your stock trading and investing.
CAMP4
Pipeline. Newsroom. Join the Adventure. Recent News. October 10, 2024. CAMP4 Announces Pricing of Initial Public Offering. Read More.
Camp4 Therapeutics initiated with an Outperform at Leerink
November 05, 2024 — 06:20 am EST. Leerink initiated coverage of Camp4 Therapeutics (CAMP) with an Outperform rating and $17 price target The firm believes CMP-CPS-001, the lead program in urea ...
CAMP4 Enters Strategic Research Collaboration to Advance Novel ...
CAMBRIDGE, Mass., Oct. 01, 2024 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation, a clinical-stage biotechnology company developing a pipeline of regulatory RNA-targeting therapeutics designed...
CAMP4 Secures $100 Million Series B Financing to Accelerate …
Jul 20, 2022 · CAMP4 Therapeutics, a biotechnology company harnessing the power of RNA to restore healthy protein expression, today announced the closing of a $100 m.
CAMP4 Raises $45 Million to Usher in a New Era of Programmable ...
Jun 15, 2021 · Biotech company CAMP4 Therapeutics announcing new financing and next phase of its scientific strategy harnessing the power of RNA to upregulate genes.
Newsroom - CAMP4
Aug 27, 2024 · CAMP4’s scientific founders share insights around regRNAs, the master controls of gene expression, and how this discovery is enabling a drug target class that could be game-changing for a wide range of diseases.